Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)

Market Cap	41.50B
Revenue (ttm)	74.52B
Net Income (ttm)	2.70B
Shares Out	n/a
EPS (ttm)	1.66
PE Ratio	15.38
Forward PE	14.25
Dividend	1.15 (4.25%)
Ex-Dividend Date	Oct 25, 2024

Volume	3,444,096
Average Volume	5,002,474
Open	26.90
Previous Close	27.03
Day's Range	26.89 - 27.22
52-Week Range	24.30 - 33.72
Beta	0.52
RSI	59.10
Earnings Date	Aug 29, 2025

About SHA:600332

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People’s Republic of China and internationally. The company operates through Great Southern TCM, Great Commerce, Great Health, and Other segments. It is also involved in the wholesale, retail, sale, import, and export of Western and Chinese medicines, medical ins...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1997
• Employees: 28,048
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600332

Financial Performance

In 2024, SHA:600332's revenue was 74.99 billion, a decrease of -0.69% compared to the previous year's 75.52 billion. Earnings were 2.84 billion, a decrease of -30.09%.